Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
IDT Australia Limited ( (AU:IDT) ) has issued an announcement.
IDT Australia Limited reported a 40.6% increase in revenues to $19,861,000 for the year ending June 30, 2025. However, the company also experienced a 49% increase in losses, amounting to $8.1 million, compared to the previous year. No dividends were declared for the current or previous financial periods. The company’s net tangible assets per ordinary security decreased from 6.67 cents to 5.09 cents. The financial statements were audited with an unmodified opinion, and the Annual General Meeting is scheduled for November 19, 2025.
More about IDT Australia Limited
IDT Australia Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of pharmaceutical products. The company provides contract manufacturing services and is involved in the production of high-quality pharmaceutical products for various markets.
Average Trading Volume: 221,396
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$28.47M
Find detailed analytics on IDT stock on TipRanks’ Stock Analysis page.